The recent surge in capital into boutique pharmaceutical companies, particularly those focusing on novel therapies and complex drug development programs, has fueled what some are calling "High Stakeholder Pharma." https://matteozunj169048.howeweb.com/40792767/high-investor-pharma-speculative-wager